Impact of the COVID-19 pandemic on patients with chronic rheumatic diseases: A study in 15 Arab countries.
Identifieur interne : 000D22 ( Main/Exploration ); précédent : 000D21; suivant : 000D23Impact of the COVID-19 pandemic on patients with chronic rheumatic diseases: A study in 15 Arab countries.
Auteurs : Nelly Ziadé [Liban] ; Lina El Kibbi [Arabie saoudite] ; Ihsane Hmamouchi [Maroc] ; Nizar Abdulateef [Iraq] ; Hussein Halabi [Arabie saoudite] ; Wafa Hamdi [Tunisie] ; Fatemah Abutiban ; Manal El Rakawi [Algérie] ; Mervat Eissa [Égypte] ; Basel Masri [Jordanie]Source :
- International journal of rheumatic diseases [ 1756-185X ] ; 2020.
Abstract
AIM
To evaluate the impact of the coronavirus disease 2019 pandemic (COVID-19) on the access to rheumatology care for patients with chronic rheumatic diseases (CRD) in the Arab countries.
METHOD
A web-based cross-sectional survey was designed by the Arab Adult Arthritis Awareness group (AAAA) consisting of 16 rheumatologists representing countries from the Arab League of Associations for Rheumatology (ArLAR) and was validated by the ArLAR scientific committee. The survey was disseminated online through social media and patients' association channels between May 8 and May 22, 2020. The steering committee developed recommendations to improve the care of patients with CRD during the COVID-19 pandemic.
RESULTS
A total of 2163 patients were included in the analysis; 72% were female; mean age was 40 years (SD 11.9). The Levant, the Gulf, and North Africa contributed almost equally to the sample. The pandemic had a significant negative impact on rheumatology visits in 82% of cases, access to hydroxychloroquine (47%), and chronic medication persistency (28%). The negative impact on rheumatology visits was associated with female gender, country, medication non-persistency, isolation due to COVID-19, and impact on mental health. Sixty-one patients (2.8%) stated that they had COVID-19, 5% said that a close contact was infected, and 47% were in isolation because of COVID-19.
CONCLUSION
The current study highlights the deleterious consequences of the COVID-19 pandemic on the continuity of rheumatology care. Therefore, an action plan, including establishing a telemedicine platform, securing drug availability, and promoting medication persistence through the appropriate communication channels, is strongly recommended.
DOI: 10.1111/1756-185X.13960
PubMed: 32892516
Affiliations:
- Algérie, Arabie saoudite, Iraq, Jordanie, Liban, Maroc, Tunisie, Égypte
- Gouvernorat de Tunis, Rabat-Salé-Kénitra
- Rabat, Tunis
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Impact of the COVID-19 pandemic on patients with chronic rheumatic diseases: A study in 15 Arab countries.</title><author><name sortKey="Ziade, Nelly" sort="Ziade, Nelly" uniqKey="Ziade N" first="Nelly" last="Ziadé">Nelly Ziadé</name><affiliation wicri:level="1"><nlm:affiliation>Saint-Joseph University, Hotel-Dieu de France Hospital, Beirut, Lebanon.</nlm:affiliation><country xml:lang="fr">Liban</country><wicri:regionArea>Saint-Joseph University, Hotel-Dieu de France Hospital, Beirut</wicri:regionArea><wicri:noRegion>Beirut</wicri:noRegion></affiliation></author><author><name sortKey="El Kibbi, Lina" sort="El Kibbi, Lina" uniqKey="El Kibbi L" first="Lina" last="El Kibbi">Lina El Kibbi</name><affiliation wicri:level="1"><nlm:affiliation>Specialized Medical Center, Riyadh, Saudi Arabia.</nlm:affiliation><country xml:lang="fr">Arabie saoudite</country><wicri:regionArea>Specialized Medical Center, Riyadh</wicri:regionArea><wicri:noRegion>Riyadh</wicri:noRegion></affiliation></author><author><name sortKey="Hmamouchi, Ihsane" sort="Hmamouchi, Ihsane" uniqKey="Hmamouchi I" first="Ihsane" last="Hmamouchi">Ihsane Hmamouchi</name><affiliation wicri:level="3"><nlm:affiliation>Laboratory of Biostatistics, Clinical Research and Epidemiology (LBRCE), Faculty of Medicine and Pharmacy, Temara Hospital, Mohammed V University, Rabat, Morocco.</nlm:affiliation><country xml:lang="fr">Maroc</country><wicri:regionArea>Laboratory of Biostatistics, Clinical Research and Epidemiology (LBRCE), Faculty of Medicine and Pharmacy, Temara Hospital, Mohammed V University, Rabat</wicri:regionArea><placeName><settlement type="city">Rabat</settlement><region nuts="2">Rabat-Salé-Kénitra</region></placeName></affiliation></author><author><name sortKey="Abdulateef, Nizar" sort="Abdulateef, Nizar" uniqKey="Abdulateef N" first="Nizar" last="Abdulateef">Nizar Abdulateef</name><affiliation wicri:level="1"><nlm:affiliation>Rheumatology Unit, Department of Medicine, College of Medicine, University of Baghdad, Baghdad, Iraq.</nlm:affiliation><country xml:lang="fr">Iraq</country><wicri:regionArea>Rheumatology Unit, Department of Medicine, College of Medicine, University of Baghdad, Baghdad</wicri:regionArea><wicri:noRegion>Baghdad</wicri:noRegion></affiliation></author><author><name sortKey="Halabi, Hussein" sort="Halabi, Hussein" uniqKey="Halabi H" first="Hussein" last="Halabi">Hussein Halabi</name><affiliation wicri:level="1"><nlm:affiliation>King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia.</nlm:affiliation><country xml:lang="fr">Arabie saoudite</country><wicri:regionArea>King Faisal Specialist Hospital and Research Center, Jeddah</wicri:regionArea><wicri:noRegion>Jeddah</wicri:noRegion></affiliation></author><author><name sortKey="Hamdi, Wafa" sort="Hamdi, Wafa" uniqKey="Hamdi W" first="Wafa" last="Hamdi">Wafa Hamdi</name><affiliation wicri:level="3"><nlm:affiliation>Department of Rheumatology, UR17SP04, Faculty of Medicine of Tunis, Kassab Institute of orthopedics, Tunis El Manar University, Tunis, Tunisia.</nlm:affiliation><country xml:lang="fr">Tunisie</country><wicri:regionArea>Department of Rheumatology, UR17SP04, Faculty of Medicine of Tunis, Kassab Institute of orthopedics, Tunis El Manar University, Tunis</wicri:regionArea><placeName><settlement type="city">Tunis</settlement><region nuts="2">Gouvernorat de Tunis</region></placeName></affiliation></author><author><name sortKey="Abutiban, Fatemah" sort="Abutiban, Fatemah" uniqKey="Abutiban F" first="Fatemah" last="Abutiban">Fatemah Abutiban</name><affiliation><nlm:affiliation>Rheumatology Unit, Department of Medicine, Jaber Alahmed Alsabah Hospital, Kuwait, State of Kuwait.</nlm:affiliation><wicri:noCountry code="subField">State of Kuwait</wicri:noCountry></affiliation></author><author><name sortKey="El Rakawi, Manal" sort="El Rakawi, Manal" uniqKey="El Rakawi M" first="Manal" last="El Rakawi">Manal El Rakawi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Rheumatology, Faculty of Medicine, Douera Hospital, Blida, Algeria.</nlm:affiliation><country xml:lang="fr">Algérie</country><wicri:regionArea>Department of Rheumatology, Faculty of Medicine, Douera Hospital, Blida</wicri:regionArea><wicri:noRegion>Blida</wicri:noRegion></affiliation></author><author><name sortKey="Eissa, Mervat" sort="Eissa, Mervat" uniqKey="Eissa M" first="Mervat" last="Eissa">Mervat Eissa</name><affiliation wicri:level="1"><nlm:affiliation>Rheumatology Department, Cairo University, Cairo, Egypt.</nlm:affiliation><country xml:lang="fr">Égypte</country><wicri:regionArea>Rheumatology Department, Cairo University, Cairo</wicri:regionArea><wicri:noRegion>Cairo</wicri:noRegion></affiliation></author><author><name sortKey="Masri, Basel" sort="Masri, Basel" uniqKey="Masri B" first="Basel" last="Masri">Basel Masri</name><affiliation wicri:level="1"><nlm:affiliation>Jordan Hospital, Amman, Jordan.</nlm:affiliation><country xml:lang="fr">Jordanie</country><wicri:regionArea>Jordan Hospital, Amman</wicri:regionArea><wicri:noRegion>Amman</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32892516</idno><idno type="pmid">32892516</idno><idno type="doi">10.1111/1756-185X.13960</idno><idno type="wicri:Area/Main/Corpus">000210</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000210</idno><idno type="wicri:Area/Main/Curation">000210</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000210</idno><idno type="wicri:Area/Main/Exploration">000210</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Impact of the COVID-19 pandemic on patients with chronic rheumatic diseases: A study in 15 Arab countries.</title><author><name sortKey="Ziade, Nelly" sort="Ziade, Nelly" uniqKey="Ziade N" first="Nelly" last="Ziadé">Nelly Ziadé</name><affiliation wicri:level="1"><nlm:affiliation>Saint-Joseph University, Hotel-Dieu de France Hospital, Beirut, Lebanon.</nlm:affiliation><country xml:lang="fr">Liban</country><wicri:regionArea>Saint-Joseph University, Hotel-Dieu de France Hospital, Beirut</wicri:regionArea><wicri:noRegion>Beirut</wicri:noRegion></affiliation></author><author><name sortKey="El Kibbi, Lina" sort="El Kibbi, Lina" uniqKey="El Kibbi L" first="Lina" last="El Kibbi">Lina El Kibbi</name><affiliation wicri:level="1"><nlm:affiliation>Specialized Medical Center, Riyadh, Saudi Arabia.</nlm:affiliation><country xml:lang="fr">Arabie saoudite</country><wicri:regionArea>Specialized Medical Center, Riyadh</wicri:regionArea><wicri:noRegion>Riyadh</wicri:noRegion></affiliation></author><author><name sortKey="Hmamouchi, Ihsane" sort="Hmamouchi, Ihsane" uniqKey="Hmamouchi I" first="Ihsane" last="Hmamouchi">Ihsane Hmamouchi</name><affiliation wicri:level="3"><nlm:affiliation>Laboratory of Biostatistics, Clinical Research and Epidemiology (LBRCE), Faculty of Medicine and Pharmacy, Temara Hospital, Mohammed V University, Rabat, Morocco.</nlm:affiliation><country xml:lang="fr">Maroc</country><wicri:regionArea>Laboratory of Biostatistics, Clinical Research and Epidemiology (LBRCE), Faculty of Medicine and Pharmacy, Temara Hospital, Mohammed V University, Rabat</wicri:regionArea><placeName><settlement type="city">Rabat</settlement><region nuts="2">Rabat-Salé-Kénitra</region></placeName></affiliation></author><author><name sortKey="Abdulateef, Nizar" sort="Abdulateef, Nizar" uniqKey="Abdulateef N" first="Nizar" last="Abdulateef">Nizar Abdulateef</name><affiliation wicri:level="1"><nlm:affiliation>Rheumatology Unit, Department of Medicine, College of Medicine, University of Baghdad, Baghdad, Iraq.</nlm:affiliation><country xml:lang="fr">Iraq</country><wicri:regionArea>Rheumatology Unit, Department of Medicine, College of Medicine, University of Baghdad, Baghdad</wicri:regionArea><wicri:noRegion>Baghdad</wicri:noRegion></affiliation></author><author><name sortKey="Halabi, Hussein" sort="Halabi, Hussein" uniqKey="Halabi H" first="Hussein" last="Halabi">Hussein Halabi</name><affiliation wicri:level="1"><nlm:affiliation>King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia.</nlm:affiliation><country xml:lang="fr">Arabie saoudite</country><wicri:regionArea>King Faisal Specialist Hospital and Research Center, Jeddah</wicri:regionArea><wicri:noRegion>Jeddah</wicri:noRegion></affiliation></author><author><name sortKey="Hamdi, Wafa" sort="Hamdi, Wafa" uniqKey="Hamdi W" first="Wafa" last="Hamdi">Wafa Hamdi</name><affiliation wicri:level="3"><nlm:affiliation>Department of Rheumatology, UR17SP04, Faculty of Medicine of Tunis, Kassab Institute of orthopedics, Tunis El Manar University, Tunis, Tunisia.</nlm:affiliation><country xml:lang="fr">Tunisie</country><wicri:regionArea>Department of Rheumatology, UR17SP04, Faculty of Medicine of Tunis, Kassab Institute of orthopedics, Tunis El Manar University, Tunis</wicri:regionArea><placeName><settlement type="city">Tunis</settlement><region nuts="2">Gouvernorat de Tunis</region></placeName></affiliation></author><author><name sortKey="Abutiban, Fatemah" sort="Abutiban, Fatemah" uniqKey="Abutiban F" first="Fatemah" last="Abutiban">Fatemah Abutiban</name><affiliation><nlm:affiliation>Rheumatology Unit, Department of Medicine, Jaber Alahmed Alsabah Hospital, Kuwait, State of Kuwait.</nlm:affiliation><wicri:noCountry code="subField">State of Kuwait</wicri:noCountry></affiliation></author><author><name sortKey="El Rakawi, Manal" sort="El Rakawi, Manal" uniqKey="El Rakawi M" first="Manal" last="El Rakawi">Manal El Rakawi</name><affiliation wicri:level="1"><nlm:affiliation>Department of Rheumatology, Faculty of Medicine, Douera Hospital, Blida, Algeria.</nlm:affiliation><country xml:lang="fr">Algérie</country><wicri:regionArea>Department of Rheumatology, Faculty of Medicine, Douera Hospital, Blida</wicri:regionArea><wicri:noRegion>Blida</wicri:noRegion></affiliation></author><author><name sortKey="Eissa, Mervat" sort="Eissa, Mervat" uniqKey="Eissa M" first="Mervat" last="Eissa">Mervat Eissa</name><affiliation wicri:level="1"><nlm:affiliation>Rheumatology Department, Cairo University, Cairo, Egypt.</nlm:affiliation><country xml:lang="fr">Égypte</country><wicri:regionArea>Rheumatology Department, Cairo University, Cairo</wicri:regionArea><wicri:noRegion>Cairo</wicri:noRegion></affiliation></author><author><name sortKey="Masri, Basel" sort="Masri, Basel" uniqKey="Masri B" first="Basel" last="Masri">Basel Masri</name><affiliation wicri:level="1"><nlm:affiliation>Jordan Hospital, Amman, Jordan.</nlm:affiliation><country xml:lang="fr">Jordanie</country><wicri:regionArea>Jordan Hospital, Amman</wicri:regionArea><wicri:noRegion>Amman</wicri:noRegion></affiliation></author></analytic><series><title level="j">International journal of rheumatic diseases</title><idno type="eISSN">1756-185X</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p><b>AIM</b></p><p>To evaluate the impact of the coronavirus disease 2019 pandemic (COVID-19) on the access to rheumatology care for patients with chronic rheumatic diseases (CRD) in the Arab countries.</p></div><div type="abstract" xml:lang="en"><p><b>METHOD</b></p><p>A web-based cross-sectional survey was designed by the Arab Adult Arthritis Awareness group (AAAA) consisting of 16 rheumatologists representing countries from the Arab League of Associations for Rheumatology (ArLAR) and was validated by the ArLAR scientific committee. The survey was disseminated online through social media and patients' association channels between May 8 and May 22, 2020. The steering committee developed recommendations to improve the care of patients with CRD during the COVID-19 pandemic.</p></div><div type="abstract" xml:lang="en"><p><b>RESULTS</b></p><p>A total of 2163 patients were included in the analysis; 72% were female; mean age was 40 years (SD 11.9). The Levant, the Gulf, and North Africa contributed almost equally to the sample. The pandemic had a significant negative impact on rheumatology visits in 82% of cases, access to hydroxychloroquine (47%), and chronic medication persistency (28%). The negative impact on rheumatology visits was associated with female gender, country, medication non-persistency, isolation due to COVID-19, and impact on mental health. Sixty-one patients (2.8%) stated that they had COVID-19, 5% said that a close contact was infected, and 47% were in isolation because of COVID-19.</p></div><div type="abstract" xml:lang="en"><p><b>CONCLUSION</b></p><p>The current study highlights the deleterious consequences of the COVID-19 pandemic on the continuity of rheumatology care. Therefore, an action plan, including establishing a telemedicine platform, securing drug availability, and promoting medication persistence through the appropriate communication channels, is strongly recommended.</p></div></front></TEI><pubmed><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">32892516</PMID><DateRevised><Year>2020</Year><Month>09</Month><Day>06</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1756-185X</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2020</Year><Month>Sep</Month><Day>05</Day></PubDate></JournalIssue><Title>International journal of rheumatic diseases</Title><ISOAbbreviation>Int J Rheum Dis</ISOAbbreviation></Journal><ArticleTitle>Impact of the COVID-19 pandemic on patients with chronic rheumatic diseases: A study in 15 Arab countries.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1111/1756-185X.13960</ELocationID><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">To evaluate the impact of the coronavirus disease 2019 pandemic (COVID-19) on the access to rheumatology care for patients with chronic rheumatic diseases (CRD) in the Arab countries.</AbstractText><AbstractText Label="METHOD" NlmCategory="METHODS">A web-based cross-sectional survey was designed by the Arab Adult Arthritis Awareness group (AAAA) consisting of 16 rheumatologists representing countries from the Arab League of Associations for Rheumatology (ArLAR) and was validated by the ArLAR scientific committee. The survey was disseminated online through social media and patients' association channels between May 8 and May 22, 2020. The steering committee developed recommendations to improve the care of patients with CRD during the COVID-19 pandemic.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 2163 patients were included in the analysis; 72% were female; mean age was 40 years (SD 11.9). The Levant, the Gulf, and North Africa contributed almost equally to the sample. The pandemic had a significant negative impact on rheumatology visits in 82% of cases, access to hydroxychloroquine (47%), and chronic medication persistency (28%). The negative impact on rheumatology visits was associated with female gender, country, medication non-persistency, isolation due to COVID-19, and impact on mental health. Sixty-one patients (2.8%) stated that they had COVID-19, 5% said that a close contact was infected, and 47% were in isolation because of COVID-19.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">The current study highlights the deleterious consequences of the COVID-19 pandemic on the continuity of rheumatology care. Therefore, an action plan, including establishing a telemedicine platform, securing drug availability, and promoting medication persistence through the appropriate communication channels, is strongly recommended.</AbstractText><CopyrightInformation>© 2020 Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Ziadé</LastName><ForeName>Nelly</ForeName><Initials>N</Initials><Identifier Source="ORCID">https://orcid.org/0000-0002-4479-7678</Identifier><AffiliationInfo><Affiliation>Saint-Joseph University, Hotel-Dieu de France Hospital, Beirut, Lebanon.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Kibbi</LastName><ForeName>Lina</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Specialized Medical Center, Riyadh, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hmamouchi</LastName><ForeName>Ihsane</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Laboratory of Biostatistics, Clinical Research and Epidemiology (LBRCE), Faculty of Medicine and Pharmacy, Temara Hospital, Mohammed V University, Rabat, Morocco.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdulateef</LastName><ForeName>Nizar</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Rheumatology Unit, Department of Medicine, College of Medicine, University of Baghdad, Baghdad, Iraq.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Halabi</LastName><ForeName>Hussein</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>King Faisal Specialist Hospital and Research Center, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hamdi</LastName><ForeName>Wafa</ForeName><Initials>W</Initials><Identifier Source="ORCID">https://orcid.org/0000-0003-3045-4831</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology, UR17SP04, Faculty of Medicine of Tunis, Kassab Institute of orthopedics, Tunis El Manar University, Tunis, Tunisia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abutiban</LastName><ForeName>Fatemah</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Rheumatology Unit, Department of Medicine, Jaber Alahmed Alsabah Hospital, Kuwait, State of Kuwait.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>El Rakawi</LastName><ForeName>Manal</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Rheumatology, Faculty of Medicine, Douera Hospital, Blida, Algeria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Eissa</LastName><ForeName>Mervat</ForeName><Initials>M</Initials><Identifier Source="ORCID">https://orcid.org/0000-0001-7999-3401</Identifier><AffiliationInfo><Affiliation>Rheumatology Department, Cairo University, Cairo, Egypt.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Masri</LastName><ForeName>Basel</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Jordan Hospital, Amman, Jordan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>09</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Int J Rheum Dis</MedlineTA><NlmUniqueID>101474930</NlmUniqueID><ISSNLinking>1756-1841</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">access to care</Keyword><Keyword MajorTopicYN="N">adherence</Keyword><Keyword MajorTopicYN="N">persistency</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>06</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>07</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>08</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>9</Month><Day>6</Day><Hour>20</Hour><Minute>38</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32892516</ArticleId><ArticleId IdType="doi">10.1111/1756-185X.13960</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239-1242.</Citation></Reference><Reference><Citation>Tang D, Comish P, Kang R. The hallmarks of COVID-19 disease. PLoS Pathog. 2020;16(5):e1008536.</Citation></Reference><Reference><Citation>Eurosurveillance Editorial Team. World Health Organization declares novel coronavirus (2019-nCoV) sixth public health emergency of international concern. Euro Surveill. 2020;25(5):2019-2020.</Citation></Reference><Reference><Citation>WHO. World Health Organization. WHO announces COVID-19 outbreak a pandemic [Internet]. 2020. Available from: http://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/news/news/2020/3/who-announces-covid-19-outbreak-a-pandemic</Citation></Reference><Reference><Citation>WHO. WHO COVID-19 Dashboard [Internet]. 2020 [cited 2020 May 31]. p. 7-9. Available from: https://covid19.who.int/?gclid=CjwKCAjwq832BRA5EiwACvCWsUXTxEZePK3xTjFXswIn7L0b_rm1mt5LGtFld8qQ3YKGqVk_I159qhoCyxcQAvD_BwE</Citation></Reference><Reference><Citation>Wendy Parmet MS. Covid-19 - The law and limits of quarantine. N Engl J Med. 2020;382(15):1-2.</Citation></Reference><Reference><Citation>Favalli EG, Agape E, Caporali R. Incidence and clinical course of COVID-19 in patients with connective tissue diseases: a descriptive observational analysis. J Rheumatol. 2020;47(8):1296. https://doi.org/10.3899/jrheum.200507</Citation></Reference><Reference><Citation>Monti S, Balduzzi S, Delvino P, Bellis E, Quadrelli VS, Montecucco C. Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies. Ann Rheum Dis. 2020;79:667-668.</Citation></Reference><Reference><Citation>Gianfrancesco MA, Hyrich KL, Gossec L, et al. Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries. Lancet Rheumatol. 2020;9913(20):19-21.</Citation></Reference><Reference><Citation>Gianfrancesco M, Hyrich KL, Adely SA, et al. Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease : data from the COVID-19 Global Rheumatology Alliance physician- reported registry. Ann Rheum Dis. 2020;1-8.</Citation></Reference><Reference><Citation>D’Silva KM, Serling-Boyd N, Wallwork R, et al. Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US “hot spot”. Ann Rheum Dis [Internet]. 2020;2019:1-7.</Citation></Reference><Reference><Citation>Ye C, Cai S, Shen G, et al. Clinical features of rheumatic patients infected with COVID-19 in Wuhan, China. Ann Rheum Dis. 2020;79(8):1007-1013.</Citation></Reference><Reference><Citation>Mikuls TR, Johnson SR, Fraenkel L, et al. American college of rheumatology guidance for the management of adult patients with rheumatic disease during the COVID-19 Pandemic. Arthritis Rheumatol. 2020;art.41301.72(8):1241-1251.</Citation></Reference><Reference><Citation>Rheumatology AC of ACR Infusion Guidance During COVID-19 Crisis [Internet]. Available from: www.rheumatology.org. [cited 2020 Apr 30].</Citation></Reference><Reference><Citation>European League Against Rheumatism. EULAR Guidance for patients COVID-19 outbreak [Internet]. 2020: 3-5. Available from: https://www.eular.org/eular_guidance_for_patients_covid19_outbreak.cfm</Citation></Reference><Reference><Citation>NHS England. Clinical guide for the management of Rheumatology patients during the coronavirus pandemic. NHS. 2020;2:1-16.</Citation></Reference><Reference><Citation>Schulze-Koops H, Specker C, Iking-Konert C, Holle J, Moosig F, Krueger K. Preliminary recommendations of the German Society of Rheumatology (DGRh eV) for the management of patients with inflammatory rheumatic diseases during the SARS-CoV-2/Covid-19 pandemic. Ann Rheum Dis. 2020;79(6):840-842.</Citation></Reference><Reference><Citation>Michaud K, Wipfler K, Shaw Y, et al. Experiences of patients with rheumatic diseases in the US during early days of the COVID-19 pandemic. ACR Open Rheumatol. 2020;2(6):335-343.</Citation></Reference><Reference><Citation>Benucci M, Damiani A, Infantino M, Manfredi M, Quartuccio L. Médicaments rhumatologiques pour le traitement de l’infection par le COVID-19. Rev du Rhum. 2020;87(3):150-152.</Citation></Reference><Reference><Citation>Ferro F, Elefante E, Baldini C, et al. COVID-19: the new challenge for rheumatologists. Clin Exp Rheumatol. 2020;1:175-180.</Citation></Reference><Reference><Citation>Graef ER, Liew JW, Putman MS, et al. Festina lente: hydroxychloroquine, covid-19 and the role of the rheumatologist. Ann Rheum Dis. 2020;79(6):734-736.</Citation></Reference><Reference><Citation>Associations AL of R. Arab Adult Awareness Arthritis Group. Available from: https://www.arabrheumatology.org/specialist-interests-groups</Citation></Reference><Reference><Citation>Eysenbach G. Improving the quality of web surveys: the checklist for reporting results of internet E-Surveys (CHERRIES). J Med Internet Res. 2004;6(3):e34. https://doi.org/10.2196/jmir.6.3.e34</Citation></Reference><Reference><Citation>Möhn N, Pul R, Kleinschnitz C, et al. Implications of COVID-19 outbreak on immune therapies in multiple sclerosis patients-lessons learned from SARS and MERS. Front Immunol. 2020;11:1059. https://doi.org/10.3389/fimmu.2020.01059. eCollection 2020</Citation></Reference><Reference><Citation>El Zorkany B, AlWahshi HA, Hammoudeh M, et al. Suboptimal management of rheumatoid arthritis in the Middle East and Africa: could the EULAR recommendations be the start of a solution? Clin Rheumatol. 2013;32(2):151-159.</Citation></Reference><Reference><Citation>Bedaiwi M, Al-Homood IA, El-Garf A, et al. Disease burden and treatment challenges of psoriatic arthritis in Africa and the Middle East. Rheumatol Int. 2019;39(8):1321-1329.</Citation></Reference><Reference><Citation>ArLAR. COVID-19 FAQ. [Internet]. 2020. Available from: https://www.arabrheumatology.org/covid-19</Citation></Reference><Reference><Citation>Fernandez-gutierrez Benjamin, Leon L, Leon Leticia, Madrid Alfredo, Rodriguez-Rodriguez Luis, Freites Dalifer, Font Judit, Mucientes Arkaitz, Ignacio Colomer Jose, Angel Jover Juan, Abasolo LydiaHospital admissions in inflammatory rheumatic diseases during the COVID-19 pandemic: incidence and role of disease modifying agents. medRxiv. 2020.https://doi.org/10.1101/2020.05.21.20108696</Citation></Reference><Reference><Citation>Government MBRS of. Arab Social Media Report: Social Media and the Internet of Things: Towards Data-Driven Policymaking in the Arab World [Internet]. 2017 [cited 2020 May 30]. Available from: https://www.arabsocialmediareport.com/home/index.aspx</Citation></Reference><Reference><Citation>Freites Nuñez DD, Leon L, Mucientes A, et al. Risk factors for hospital admission related to COVID-19 in patients with autoimmune inflammatory rheumatic diseases. Annals of the Rheumatic Diseases. 2020. Published Online First: 07 August 2020. http://doi.org/10.1136/annrheumdis-2020-217984</Citation></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>Algérie</li><li>Arabie saoudite</li><li>Iraq</li><li>Jordanie</li><li>Liban</li><li>Maroc</li><li>Tunisie</li><li>Égypte</li></country><region><li>Gouvernorat de Tunis</li><li>Rabat-Salé-Kénitra</li></region><settlement><li>Rabat</li><li>Tunis</li></settlement></list><tree><noCountry><name sortKey="Abutiban, Fatemah" sort="Abutiban, Fatemah" uniqKey="Abutiban F" first="Fatemah" last="Abutiban">Fatemah Abutiban</name></noCountry><country name="Liban"><noRegion><name sortKey="Ziade, Nelly" sort="Ziade, Nelly" uniqKey="Ziade N" first="Nelly" last="Ziadé">Nelly Ziadé</name></noRegion></country><country name="Arabie saoudite"><noRegion><name sortKey="El Kibbi, Lina" sort="El Kibbi, Lina" uniqKey="El Kibbi L" first="Lina" last="El Kibbi">Lina El Kibbi</name></noRegion><name sortKey="Halabi, Hussein" sort="Halabi, Hussein" uniqKey="Halabi H" first="Hussein" last="Halabi">Hussein Halabi</name></country><country name="Maroc"><region name="Rabat-Salé-Kénitra"><name sortKey="Hmamouchi, Ihsane" sort="Hmamouchi, Ihsane" uniqKey="Hmamouchi I" first="Ihsane" last="Hmamouchi">Ihsane Hmamouchi</name></region></country><country name="Iraq"><noRegion><name sortKey="Abdulateef, Nizar" sort="Abdulateef, Nizar" uniqKey="Abdulateef N" first="Nizar" last="Abdulateef">Nizar Abdulateef</name></noRegion></country><country name="Tunisie"><region name="Gouvernorat de Tunis"><name sortKey="Hamdi, Wafa" sort="Hamdi, Wafa" uniqKey="Hamdi W" first="Wafa" last="Hamdi">Wafa Hamdi</name></region></country><country name="Algérie"><noRegion><name sortKey="El Rakawi, Manal" sort="El Rakawi, Manal" uniqKey="El Rakawi M" first="Manal" last="El Rakawi">Manal El Rakawi</name></noRegion></country><country name="Égypte"><noRegion><name sortKey="Eissa, Mervat" sort="Eissa, Mervat" uniqKey="Eissa M" first="Mervat" last="Eissa">Mervat Eissa</name></noRegion></country><country name="Jordanie"><noRegion><name sortKey="Masri, Basel" sort="Masri, Basel" uniqKey="Masri B" first="Basel" last="Masri">Basel Masri</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000D22 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000D22 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32892516
|texte= Impact of the COVID-19 pandemic on patients with chronic rheumatic diseases: A study in 15 Arab countries.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32892516" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |